▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1654 by analyst upside · 2026-06-27
ISRG
Intuitive Surgical, Inc.
Healthcare · Market Cap $143B · P/E 49.2x
ANALYST PRICE TARGET
+39.6%
implied upside to consensus target
Current Price $404.7
Consensus Target $565.08
Bull Target $750.0
Bear Target $366.0
Analysts Covering 29
ANALYST CONSENSUS — BUY
Strong Buy
6
Buy
14
Hold
7
Sell
2
52-Week Low $396.68
52-Week High $603.88
YTD Return -28.0%
FUNDAMENTALS
Market Cap $143B
P/E Ratio (TTM) 49.2x
Forward P/E 34.3x
EPS (TTM) $8.23
PEG Ratio 2.11
Dividend Yield N/A
Revenue (TTM) $10.6B
Profit Margin 28.2%
52-WEEK RANGE
52-Week Low $396.68
52-Week High $603.88
Current Price $404.7
Bear Target $366.0
Bull Target $750.0
● Now $404.7 ● Target $565.08
TRADING DATA
Avg Volume 2.3M
YTD Return -28.0%
Analyst Count 29
Consensus Buy
Upside to Target +39.6%
Last Updated 2026-06-27

ANALYST SUMMARY

Intuitive Surgical, Inc. (ISRG) is currently trading at $404.7 with a Wall Street consensus price target of $565.08, implying potential upside of 39.6% over the next 12 months. 29 analysts currently cover ISRG, with a consensus rating of Buy — 69% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $750.0, while the most cautious has a target of $366.0.

ISRG operates in the Healthcare sector with a market capitalisation of $143B. The stock is down 28.0% year-to-date and is currently trading near the lower end of its 52-week range of $396.68 – $603.88.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

DHR +23.5%
Danaher Corporation
$139B · P/E 38.0x · Buy
ABT +23.8%
Abbott Laboratories
$164B · P/E 26.4x · Buy
SYK +16.3%
Stryker Corporation
$128B · P/E 36.6x · Buy
GILD +23.2%
Gilead Sciences, Inc.
$159B · P/E 17.4x · Buy
VRTX +11.7%
Vertex Pharmaceuticals Incorporated
$125B · P/E 28.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ISRG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B of A Securities — Reiterated
Buy → Buy 2026-05-18 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-04-23 Building track record
Leerink Partners — Reiterated
Outperform → Outperform 2026-04-22 29% win rate (7 calls)
Baird — Reiterated
Outperform → Outperform 2026-04-22 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2026-04-22 14% win rate (7 calls)
BTIG reit
Buy → Buy 2026-04-22 38% win rate (8 calls)
Truist Securities — Reiterated
Buy → Buy 2026-04-15 Building track record
Mizuho — Reiterated
Neutral → Neutral 2026-04-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →